Chembio

$5.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+1.14%) Today
-$0.04 (-0.75%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Chembio and other stocks, options, and ETFs commission-free!

About CEMI

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. The listed name for CEMI is Chembio Diagnostics, Inc. Common Stock.

CEO
Richard L. Eberly
Employees
324
Headquarters
Hauppauge, New York
Founded
1985
Market Cap
107.74M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.32M
High Today
$5.46
Low Today
$5.18
Open Price
$5.27
Volume
1.39M
52 Week High
$15.89
52 Week Low
$2.25

Collections

CEMI Earnings

-$0.42
-$0.28
-$0.14
-$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like